The Pharmaceutical Research and Manufacturers of America failed to convince the Office of the U.S. Trade Representative to elevate India, Turkey and Canada on its lists of countries that do not provide sufficient protection of intellectual property rights.
The USTR’s 2014 Special 301 Report, released on April 30, places 10 countries on its “Priority Watch List” and 27 countries on its “Watch List.” The annual report identifies U.S. trading partners that USTR has determined provide inadequate protection of IP rights or deny fair and equitable market access
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?